KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Opko Health (OPK) over the last 13 years, with Sep 2025 value amounting to $763,000.

  • Opko Health's Gains from Investment Securities was N/A to $763,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year change of. This contributed to the annual value of $45.5 million for FY2024, which is 12.28% down from last year.
  • According to the latest figures from Q3 2025, Opko Health's Gains from Investment Securities is $763,000, which was down 95.71% from $17.8 million recorded in Q2 2025.
  • Opko Health's 5-year Gains from Investment Securities high stood at $23.4 million for Q4 2023, and its period low was -$27.4 million during Q4 2022.
  • In the last 3 years, Opko Health's Gains from Investment Securities had a median value of $1.1 million in 2024 and averaged $5.7 million.
  • Examining YoY changes over the last 5 years, Opko Health's Gains from Investment Securities showed a top increase of 335.66% in 2022 and a maximum decrease of 2,888.92% in 2022.
  • Over the past 5 years, Opko Health's Gains from Investment Securities (Quarterly) stood at $984,000 in 2021, then plummeted by 2,888.92% to -$27.4 million in 2022, then skyrocketed by 185.26% to $23.4 million in 2023, then slumped by 73.47% to $6.2 million in 2024, then soared by 93.70% to $763,000 in 2025.
  • Its last three reported values are $763,000 in Q3 2025, $17.8 million for Q2 2025, and $2.1 million during Q1 2025.